-
1دورية أكاديمية
المؤلفون: de Lavallade, Hugues, Khoder, Ahmad, Hart, Melanie, Sarvaria, Anushruti, Sekine, Takuya, Alsuliman, Abdullah, Mielke, Stephan, Bazeos, Alexandra, Stringaris, Kate, Ali, Sara, Milojkovic, Dragana, Foroni, Letizia, Chaidos, Aristeidis, Cooper, Nichola, Gabriel, Ian, Apperley, Jane, Belsey, Sarah, Flanagan, Bob, Goldman, John, Shpall, Elizabeth J., Kelleher, Peter, Marin, David, Rezvani, Katayoun
المصدر: de Lavallade , H , Khoder , A , Hart , M , Sarvaria , A , Sekine , T , Alsuliman , A , Mielke , S , Bazeos , A , Stringaris , K , Ali , S , Milojkovic , D , Foroni , L , Chaidos , A , Cooper , N , Gabriel , I , Apperley , J , Belsey , S , Flanagan , B , Goldman , J , Shpall , E J , Kelleher , P , Marin , D & Rezvani , K 2013 , ' Tyrosine kinase inhibitors ....
مصطلحات موضوعية: CHRONIC MYELOID-LEUKEMIA, COMMON VARIABLE IMMUNODEFICIENCY, LYMPHOCYTES IN-VITRO, CD8(+) T-CELLS, IMATINIB MESYLATE, DASATINIB THERAPY, CHRONIC-PHASE, ACTIVATION, DISEASE, PROLIFERATION
الإتاحة: https://doi.org/10.1182/blood-2012-11-465039Test
https://kclpure.kcl.ac.uk/portal/en/publications/0beb6900-3ed4-4bae-b029-e8a72b42eeb5Test -
2دورية أكاديمية
المؤلفون: de Lavallade, Hugues, Khoder, Ahmad, Hart, Melanie, Sarvaria, Anushruti, Sekine, Takuya, Alsuliman, Abdullah, Mielke, Stephan, Bazeos, Alexandra, Stringaris, Kate, Ali, Sara, Milojkovic, Dragana, Foroni, Letizia, Chaidos, Aristeidis, Cooper, Nichola, Gabriel, Ian, Apperley, Jane, Belsey, Sarah, Flanagan, Bob, Goldman, John, Shpall, Elizabeth J., Kelleher, Peter, Marin, David, Rezvani, Katayoun
المصدر: de Lavallade , H , Khoder , A , Hart , M , Sarvaria , A , Sekine , T , Alsuliman , A , Mielke , S , Bazeos , A , Stringaris , K , Ali , S , Milojkovic , D , Foroni , L , Chaidos , A , Cooper , N , Gabriel , I , Apperley , J , Belsey , S , Flanagan , B , Goldman , J , Shpall , E J , Kelleher , P , Marin , D & Rezvani , K 2013 , ' Tyrosine kinase inhibitors ....
مصطلحات موضوعية: CHRONIC MYELOID-LEUKEMIA, COMMON VARIABLE IMMUNODEFICIENCY, LYMPHOCYTES IN-VITRO, CD8(+) T-CELLS, IMATINIB MESYLATE, DASATINIB THERAPY, CHRONIC-PHASE, ACTIVATION, DISEASE, PROLIFERATION
الإتاحة: https://doi.org/10.1182/blood-2012-11-465039Test
https://kclpure.kcl.ac.uk/portal/en/publications/tyrosine-kinase-inhibitors-impair-bcell-immune-responses-in-cml-through-offtarget-inhibition-of-kinases-important-for-cell-signalingTest(0beb6900-3ed4-4bae-b029-e8a72b42eeb5).html